TP53 and pancreatic ductal adenocarcinoma: In this study, we show that targeted disruption of tp53 at the DNA binding domain in X. tropicalis predisposed the frogs to nevi and melanomas in addition to soft tissue sarcomas and pancreatic ductal adenocarcinoma.